美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Therapeutics

4.67

+0.08001.74%

盤後：4.670.00000.00%19:30 EDT

成交量：54.22萬

成交額：255.19萬

市值：1.46億

市盈率：-1.13

高：4.81

開：4.58

低：4.58

收：4.59

52周最高：50.40

52周最低：4.54

股本：3,129.00萬

流通股本：1,839.33萬

量比：1.02

換手率：2.95%

股息：- -

股息率：- -

每股收益(TTM):-4.1300

每股收益(LYR):-2.8503

淨資產收益率：-59.21%

總資產收益率：-37.36%

市淨率：0.67

市盈率(LYR):-1.64

資料載入中...

總覽公司新聞資訊公告

小分子抗癌療法開發商BlossomHill Therapeutics(BLSM.US)申請美股上市擬籌資至多1億美元

缺氧療法生物科技公司NuvOx Therapeutics(NUOX.US)申請美股IPO，擬募資2000萬美元

新聞稿：Glucotrack與Lōkahi Therapeutics完成戰略業務合併，建立Lōkahi控制的公開平台

信達生物與 Spero Therapeutics就IBI355（第三代抗CD40L單抗，臨床II期準備階段）達成獨家許可協議

Stoke Therapeutics任命Thomas McCauley博士為首席科學官

环球市场播报

Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會

Cardiol Therapeutics將出席B. Riley Mind, Muscle & Vision峯會爐邊談話

环球市场播报

雲頂新耀宣佈完成與Travere Therapeutics關於希布替尼（EVER001）的獨家授權許可與合作協議交割

Incyte(INCY)以12.5億美元完成收購Vega Therapeutics 拓寬血液學管線佈局

Lenz Therapeutics推出新型遠程醫療處方方案，加速老花眼患者獲取Vizz®治療

生物技術公司Scribe Therapeutics(SCTX.US)申請美股IPO 擬籌資至多7500萬美元

聯合治療公司以1.4億美元現金收購生物技術公司Thymmune Therapeutics。

Stoke Therapeutics完成Dravet綜合徵藥物關鍵III期試驗患者入組

环球市场播报

Unicycive Therapeutics股價下跌45.8%，此前美國食品藥品監督管理局拒絕批准該公司的腎病藥物。

新聞稿：Akari Therapeutics 完成先前宣佈的PIPE融資，強化資產負債表以迎接關鍵臨床與監管里程碑

新聞稿：Rani Therapeutics任命尼古拉斯·馬埃斯塔斯為首席財務官

益普生將以最高17.5億美元收購Kartos Therapeutics

分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降

Lenz Therapeutics與Arrotex Pharmaceuticals就Vizz™在澳大利亞和新西蘭達成獨家許可與商業化協議

Definium Therapeutics(DFTX)宣佈7億美元增發公開募股定價每股34美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/LENZ/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":4.67,"timestamp":1787688000000,"preClose":4.59,"halted":0,"volume":542227,"hourTrading":{"tag":"盘后","latestPrice":4.67,"preClose":4.67,"latestTime":"19:30 EDT","volume":864,"amount":4034.88,"timestamp":1787700602836,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01742919389978215,"floatShares":18393300,"shares":31289969,"eps":-4.13,"marketStatus":"未開盤","change":0.08,"latestTime":"08-25 16:00:00 EDT","open":4.58,"high":4.81,"low":4.58,"amount":2551900.6609229,"amplitude":0.050109,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.13,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":4.59,"preHourTrading":{"tag":"盘前","latestPrice":4.58,"preClose":4.59,"latestTime":"09:28 EDT","volume":519,"amount":2388.0959789999997,"timestamp":1787664489065,"change":-0.01,"changeRate":-0.002179,"amplitude":0.023551},"postHourTrading":{"tag":"盘后","latestPrice":4.67,"preClose":4.67,"latestTime":"19:30 EDT","volume":864,"amount":4034.88,"timestamp":1787700602836,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.019734,"impliedVol":2.135,"impliedVolPercentile":0.9163},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":18393300,"roa":"-37.36%","roe":"-59.21%","lyrEps":-2.850329,"volumeRatio":1.019734,"shares":31289969,"dividePrice":0,"high":4.81,"amplitude":0.050109,"preClose":4.59,"low":4.58,"week52Low":4.535,"pbRate":"0.67","psRate":"6.80","week52High":50.4,"institutionHeld":0,"latestPrice":4.67,"eps":-4.13,"divideRate":0,"volume":542227,"delay":0,"ttmEps":-4.13,"open":4.58,"prevYearClose":16,"prevWeekClose":4.68,"prevMonthClose":5.3,"prevQuarterClose":5.68,"fiveDayClose":4.77,"twentyDayClose":5.88,"sixtyDayClose":7.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LENZ","fiscalQuarterEnding":"2026/06","expectedEps":-1.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-1.02},{"market":"US","date":"2026-05-11","symbol":"LENZ","fiscalQuarterEnding":"2026/03","expectedEps":-1.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-1.32},{"market":"US","date":"2026-03-24","symbol":"LENZ","fiscalQuarterEnding":"2025/12","expectedEps":-0.91,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-1.16},{"market":"US","date":"2026-01-07","symbol":"LENZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1767762000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-05","symbol":"LENZ","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1786593600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2026-08-24","current":-1.130751,"percent":0.996575,"low":-26.69966,"twenty":-16.312787,"median":-9.872625,"eighty":-5.462149,"high":-1.147074,"avg":-10.709507,"sd":6.115347,"marketCap":147047205},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525},{"date":"2025-08-29","current":-20.793619,"twenty":-16.611183,"median":-11.233899,"eighty":-7.743848,"marketCap":1089544067},{"date":"2025-09-05","current":-21.729877,"twenty":-16.749673,"median":-11.252126,"eighty":-7.89274,"marketCap":1138602072},{"date":"2025-09-12","current":-22.214335,"twenty":-16.928962,"median":-11.290275,"eighty":-7.953319,"marketCap":1163986737},{"date":"2025-09-19","current":-22.693351,"twenty":-17.073997,"median":-11.339198,"eighty":-7.982513,"marketCap":1189086182},{"date":"2025-09-26","current":-21.789753,"twenty":-17.210778,"median":-11.419321,"eighty":-7.998378,"marketCap":1141739502},{"date":"2025-10-03","current":-26.302295,"twenty":-17.347559,"median":-11.473592,"eighty":-8.003646,"marketCap":1378187678},{"date":"2025-10-10","current":-25.175521,"twenty":-17.497557,"median":-11.534645,"eighty":-8.0071,"marketCap":1319146940},{"date":"2025-10-17","current":-22.018374,"twenty":-17.690689,"median":-11.749464,"eighty":-8.107241,"marketCap":1153718783},{"date":"2025-10-24","current":-16.034033,"twenty":-17.707197,"median":-11.991418,"eighty":-8.145558,"marketCap":840151237},{"date":"2025-10-31","current":-15.563946,"twenty":-17.690689,"median":-12.292165,"eighty":-8.168128,"marketCap":815519652},{"date":"2025-11-07","current":-10.439663,"twenty":-17.665927,"median":-12.292165,"eighty":-8.196087,"marketCap":614718687},{"date":"2025-11-14","current":-14.07658,"twenty":-17.595178,"median":-12.325665,"eighty":-8.25011,"marketCap":828871278},{"date":"2025-11-21","current":-14.730193,"twenty":-17.553908,"median":-12.761733,"eighty":-8.286974,"marketCap":867357940},{"date":"2025-11-28","current":-16.218091,"twenty":-17.524554,"median":-12.861347,"eighty":-8.308212,"marketCap":954969853},{"date":"2025-12-05","current":-14.825843,"twenty":-17.466248,"median":-13.119398,"eighty":-8.337771,"marketCap":872990135},{"date":"2025-12-12","current":-13.01911,"twenty":-17.42774,"median":-13.221067,"eighty":-8.354198,"marketCap":766604240},{"date":"2025-12-19","current":-9.070865,"twenty":-17.407695,"median":-13.037789,"eighty":-8.414622,"marketCap":534119770},{"date":"2025-12-26","current":-9.108063,"twenty":-17.390007,"median":-12.866196,"eighty":-8.500376,"marketCap":536310068},{"date":"2026-01-02","current":-8.502276,"twenty":-17.333409,"median":-12.777948,"eighty":-8.502276,"marketCap":500639504},{"date":"2026-01-09","current":-8.098418,"twenty":-17.315721,"median":-12.328345,"eighty":-8.502276,"marketCap":476859127},{"date":"2026-01-16","current":-9.639455,"twenty":-17.280347,"median":-12.249123,"eighty":-8.498134,"marketCap":567600037},{"date":"2026-01-23","current":-11.302713,"twenty":-17.228465,"median":-12.093174,"eighty":-8.501448,"marketCap":665537640},{"date":"2026-01-30","current":-9.448154,"twenty":-17.210778,"median":-11.871572,"eighty":-8.502276,"marketCap":556335648},{"date":"2026-02-06","current":-7.42355,"twenty":-17.195449,"median":-11.633633,"eighty":-8.39709,"marketCap":437120866},{"date":"2026-02-13","current":-6.892157,"twenty":-17.156729,"median":-11.509772,"eighty":-8.290687,"marketCap":405830897},{"date":"2026-02-20","current":-6.403276,"twenty":-17.117721,"median":-11.432889,"eighty":-8.236123,"marketCap":377044126},{"date":"2026-02-27","current":-7.184423,"twenty":-17.08343,"median":-11.396709,"eighty":-8.118629,"marketCap":423040380},{"date":"2026-03-06","current":-6.40859,"twenty":-17.073997,"median":-11.306259,"eighty":-7.995871,"marketCap":377357026},{"date":"2026-03-13","current":-6.281056,"twenty":-17.036729,"median":-11.290275,"eighty":-7.848663,"marketCap":369847433},{"date":"2026-03-20","current":-6.105697,"twenty":-16.999628,"median":-11.252126,"eighty":-7.671592,"marketCap":359521743},{"date":"2026-03-27","current":-3.413108,"twenty":-16.980184,"median":-11.233899,"eighty":-7.489126,"marketCap":280308282},{"date":"2026-04-02","current":-3.569637,"twenty":-16.958959,"median":-11.220775,"eighty":-7.447644,"marketCap":293163583},{"date":"2026-04-10","current":-3.54673,"twenty":-16.933679,"median":-11.193196,"eighty":-7.269441,"marketCap":291282320},{"date":"2026-04-17","current":-3.680353,"twenty":-16.916201,"median":-11.141188,"eighty":-7.181235,"marketCap":302256358},{"date":"2026-04-24","current":-3.493281,"twenty":-16.878888,"median":-11.077981,"eighty":-6.952736,"marketCap":286892705},{"date":"2026-05-01","current":-3.428379,"twenty":-16.817122,"median":-11.044571,"eighty":-6.825202,"marketCap":281562458},{"date":"2026-05-08","current":-3.710895,"twenty":-16.761494,"median":-10.861657,"eighty":-6.578636,"marketCap":304764709},{"date":"2026-05-15","current":-2.097082,"twenty":-16.730518,"median":-10.778852,"eighty":-6.457565,"marketCap":228573532},{"date":"2026-05-22","current":-2.163245,"twenty":-16.709792,"median":-10.723495,"eighty":-6.429023,"marketCap":235785042},{"date":"2026-05-29","current":-2.298448,"twenty":-16.694346,"median":-10.694071,"eighty":-6.404339,"marketCap":250521608},{"date":"2026-06-05","current":-2.071192,"twenty":-16.632408,"median":-10.560046,"eighty":-6.370576,"marketCap":225751636},{"date":"2026-06-12","current":-1.869826,"twenty":-16.608825,"median":-10.439663,"eighty":-6.329861,"marketCap":203803561},{"date":"2026-06-18","current":-1.8238,"twenty":-16.599392,"median":-10.388191,"eighty":-6.238545,"marketCap":198786857},{"date":"2026-06-26","current":-1.585037,"twenty":-16.591349,"median":-10.356288,"eighty":-6.201347,"marketCap":172762710},{"date":"2026-07-02","current":-1.665584,"twenty":-16.562409,"median":-10.323331,"eighty":-6.136275,"marketCap":181541941},{"date":"2026-07-10","current":-1.665584,"twenty":-16.458857,"median":-10.297741,"eighty":-6.098214,"marketCap":181541941},{"date":"2026-07-17","current":-1.403808,"twenty":-16.42504,"median":-10.207556,"eighty":-5.994366,"marketCap":153009442},{"date":"2026-07-24","current":-1.452711,"twenty":-16.399781,"median":-10.175633,"eighty":-5.904593,"marketCap":158339689},{"date":"2026-07-31","current":-1.656954,"twenty":-16.359791,"median":-10.130408,"eighty":-5.831073,"marketCap":180601309},{"date":"2026-08-07","current":-1.501614,"twenty":-16.336075,"median":-10.052902,"eighty":-5.780516,"marketCap":163669936},{"date":"2026-08-14","current":-1.147074,"twenty":-16.332656,"median":-9.910465,"eighty":-5.64279,"marketCap":144533577},{"date":"2026-08-21","current":-1.162036,"twenty":-16.31728,"median":-9.875604,"eighty":-5.484249,"marketCap":146418798},{"date":"2026-08-24","current":-1.167023,"twenty":-16.312787,"median":-9.872625,"eighty":-5.462149,"marketCap":147047205}],"updateTime":1787707434981},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652298740","title":"小分子抗癌療法開發商BlossomHill Therapeutics(BLSM.US)申請美股上市 擬籌資至多1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652298740","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652298740?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 15:20","pubTimestamp":1784532012,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，BlossomHill Therapeutics是一家管线已推进至二期临床阶段的生物技术企业，专注于开发小分子抗癌疗法。该公司于上周五向美国证券交易委员会递交招股书，拟通过首次公开募股募资至多1亿美元。BlossomHill Therapeutics专注研发小分子抗癌药物：先找出现有疗法的结构缺陷，再设计新的化合物来克服这些缺陷。BlossomHill Therapeutics于2026年4月24日秘密提交了上市申请。摩根大通、Leerink Partners、Guggenheim Securities、LifeSci Capital和HC Wainwright是此次交易的联合承销商。定价条款未披露。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4007","BK4539","IPOS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652298685","title":"缺氧療法生物科技公司NuvOx Therapeutics(NUOX.US)申請美股IPO，擬募資2000萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652298685","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652298685?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 14:55","pubTimestamp":1784530507,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","FRHC","KCE","LENZ","SYNB","BK4588","BK4539","MEDX","GDOC","BK4585","XBI","BK4127","BK4007","BK4139","BK4581","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182696709","title":"新聞稿：Glucotrack與Lōkahi Therapeutics完成戰略業務合併，建立Lōkahi控制的公開平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1182696709","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182696709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 05:45","pubTimestamp":1784065528,"startTime":"0","endTime":"0","summary":"Glucotrack, Inc.今日宣布，其与Lōkahi Therapeutics的战略业务合并已正式完成。本次交易的结构设计使得Lōkahi Therapeutics成为合并后公司的运营及控制主体，并利用Glucotrack的公开市场平台来支持长期增长及资本获取。在交易完成之际，Lōkahi Therapeutics的证券持有人获得了Glucotrack普通股与可转换优先股的组合。届时，在完全稀释基础上，并受交易相关融资及常规调整影响，Lōkahi Therapeutics的证券持有人将持有合并后公司约90%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCTK","LENZ","BK4082","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651174232","title":"信達生物與 Spero Therapeutics就IBI355（第三代抗CD40L單抗，臨床II期準備階段）達成獨家許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2651174232","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651174232?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 18:00","pubTimestamp":1784023200,"startTime":"0","endTime":"0","summary":"Spero计划于2027年第二季度启动IBI355治疗IgG4-RD患者的临床II期研究；信达生物计划于2027年初前在中国启动IBI355治疗SjD的临床II期研究。我们非常高兴与Spero Therapeutics达成合作，共同推进IBI355的全球开发。结合信达生物和Spero Therapeutics在自身免疫领域的临床资源和专注投入，我们将共同加速这一差异化疗法的研发进程，致力于为慢性病患者带来新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5003988_ZH03988_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5003988_ZH03988_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4139","BK4007","01801","LU2488822045.USD","KURE","LU2328871848.SGD","LU2097828631.EUR","LU2097828557.USD","LU2242644610.SGD","BK1583","LENZ","BK1161","HK0000165453.HKD","BK1589","BK4539","LU2097828474.EUR","LU0502904849.HKD","LU0455707207.USD","LU1969619763.USD","LU2097828714.EUR","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651722111","title":"Stoke Therapeutics任命Thomas McCauley博士為首席科學官","url":"https://stock-news.laohu8.com/highlight/detail?id=2651722111","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651722111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:49","pubTimestamp":1783946940,"startTime":"0","endTime":"0","summary":"生物技术公司Stoke Therapeutics近日宣布，任命Thomas McCauley博士为首席科学官，负责领导公司的科学战略，并推动其基于RNA药物平台的管线扩展与临床推进。他曾担任Neptune Bio的总裁兼首席执行官，并先后在Omega Therapeutics、Macrolide Pharmaceuticals和Translate Bio担任首席科学官。　　Stoke Therapeutics专注于利用其专有的TANGO技术开发反义寡核苷酸药物，以选择性恢复蛋白质水平。Stoke与渤健已就此药物建立战略合作，共同进行开发和商业化。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-13/doc-inihsisy8947593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183275253","title":"Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1183275253","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183275253?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946106,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Pliant Therapeutics今日宣布，任命Flavia Borellini博士与Robert Iannone博士为公司董事会新成员。这两项任命为董事会注入了深厚的全球肿瘤药物开发经验，并进一步强化了其在运营与监管事务方面的专业能力。目前，除了在Pliant任职外，他还担任Autolus Therapeutics的董事会成员。关于Pliant Therapeutics, Inc.：Pliant Therapeutics是一家临床阶段的生物制药公司，专注于基于整合素的疗法的发现与开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LENZ","BK4232","BK4139","R","IBB","BK4007","BK4022","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650924739","title":"Cardiol Therapeutics將出席B. Riley Mind, Muscle & Vision峯會爐邊談話","url":"https://stock-news.laohu8.com/highlight/detail?id=2650924739","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650924739?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 20:54","pubTimestamp":1783601672,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics Inc．宣布，将参加于2026年7月16日在波士顿举行的B． Riley Securities Mind， Muscle & Vision Summit，并在当日下午12：20进行炉边谈话。　　此次峰会为B． Riley Securities主办的单一医疗健康会议，聚焦神经学、肌肉及眼科疾病领域的创新成果。　　Cardiol Therapeutics是一家处于后期阶段的生命科学公司，专注于推进心脏疾病抗炎和抗纤维化疗法的开发。　　Cardiol目前正在推进MAVERIC项目，评估CardiolRx治疗复发性心包炎的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihfihx8573744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649935543","title":"雲頂新耀宣佈完成與Travere Therapeutics關於希布替尼（EVER001）的獨家授權許可與合作協議交割","url":"https://stock-news.laohu8.com/highlight/detail?id=2649935543","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649935543?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:13","pubTimestamp":1783419180,"startTime":"0","endTime":"0","summary":"上海2026年7月7日 /美通社/ -- 云顶新耀是一家专注于创新药研发、临床开发、制造及商业化的生物制药公司，今日宣布，已根据协议条款完成与Travere Therapeutics, Inc.关于EVER001的独家授权许可与合作协议交割，表明该交易已满足必要监管程序等约定交割条件，充分体现了公司承诺兑现的执行能力。双方合作将正式进入实施阶段，并将共同推进EVER001的后续开发与商业化。根据协议，Travere Therapeutics将获得EVER001除大中华区及部分东南亚国家以外区域的独家开发及商业化权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/4999306_ZH99306_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4999306_ZH99306_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4539","BK4139","BK4007","LENZ","FFTY","BK1583","BK1161","BK1574","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649858622","title":"Incyte(INCY)以12.5億美元完成收購Vega Therapeutics 拓寬血液學管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2649858622","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649858622?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 21:19","pubTimestamp":1783343950,"startTime":"0","endTime":"0","summary":"根据双方此前达成的股票购买协议，Incyte已支付12.5亿美元的预付款，收购了Vega Therapeutics的全部发行在外股份。此外，Star Therapeutics未来还有权获得最高达7.5亿美元的商业销售里程碑付款。通过本次收购，Incyte成功将Vega的核心资产——创新单克隆抗体VGA039收入囊中。目前，该药物正在全球开展一项名为VIVID-6的单臂交叉3期临床试验，以评估其在各类血管性血友病患者中的安全性和有效性。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/NTkwMTRiMmRhYjljZTk4MGRjMGViZTQ1NDI1NzQxMTc4OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTkwMTRiMmRhYjljZTk4MGRjMGViZTQ1NDI1NzQxMTc4OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302236","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","BK4588","BK4585","BK4539","IDNA","INCY","LENZ","BK4550","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183410479","title":"Lenz Therapeutics推出新型遠程醫療處方方案，加速老花眼患者獲取Vizz®治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1183410479","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183410479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 20:22","pubTimestamp":1783340531,"startTime":"0","endTime":"0","summary":"Lenz Therapeutics宣布推出一种新型远程医疗处方方案，旨在加速老花眼患者获取Vizz®治疗。此举将简化患者的治疗流程，提高治疗的可及性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649197641","title":"生物技術公司Scribe Therapeutics(SCTX.US)申請美股IPO 擬籌資至多7500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649197641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649197641?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:30","pubTimestamp":1783323045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","HELX","FRHC","BK4127","KCE","WDNA","IPOS","LENZ","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648509782","title":"聯合治療公司以1.4億美元現金收購生物技術公司Thymmune Therapeutics。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648509782","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648509782?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 18:31","pubTimestamp":1782988300,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647551730","title":"Stoke Therapeutics完成Dravet綜合徵藥物關鍵III期試驗患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2647551730","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647551730?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 21:47","pubTimestamp":1782827220,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics近日宣布，其针对Dravet综合征的潜在疾病修饰疗法zorevunersen的全球III期EMPEROR研究已完成全部162名患者的入组工作。这一里程碑的达成，标志着该药物向提交新药申请、尽快惠及患者迈出了关键一步。　　此前，公司预计将在2026年第二季度完成约150名患者的入组。此次公布的162名患者入组数量超出了这一预期。　　Zorevunersen是一款首创的反义寡核苷酸药物，旨在通过增加脑细胞中非突变SCN1A基因拷贝的功能性NaV1.1蛋白表达，从根本上治疗Dravet综合征。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-iniffcps6559776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","BK4539","LENZ","III","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647455165","title":"Unicycive Therapeutics股價下跌45.8%，此前美國食品藥品監督管理局拒絕批准該公司的腎病藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647455165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647455165?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 21:31","pubTimestamp":1782826311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UNCY","BK4539","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132616293","title":"新聞稿：Akari Therapeutics 完成先前宣佈的PIPE融資，強化資產負債表以迎接關鍵臨床與監管里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1132616293","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132616293?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 20:47","pubTimestamp":1782737248,"startTime":"0","endTime":"0","summary":"Akari Therapeutics PLC  是一家专注于开发搭载新型RNA剪接调节剂有效载荷的抗体药物偶联物的肿瘤学生物技术公司。该公司近日宣布，已通过将剩余计划投资交割合并为单一融资事件，完成了先前公布的私募股权投资。结合五月份完成的认股权证行权，公司在2026年第二季度总计获得了约830万美元资本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PIPE","AKTX","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146816793","title":"新聞稿：Rani Therapeutics任命尼古拉斯·馬埃斯塔斯為首席財務官","url":"https://stock-news.laohu8.com/highlight/detail?id=1146816793","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146816793?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 20:02","pubTimestamp":1782734563,"startTime":"0","endTime":"0","summary":"临床阶段生物治疗公司Rani Therapeutics Holdings, Inc.今日宣布，任命尼古拉斯·马埃斯塔斯为首席财务官，即刻生效。Rani Therapeutics首席执行官塔拉特·伊姆兰表示：“我们很高兴欢迎尼古拉斯担任我们的新任首席财务官。他在生物制药资本市场和企业战略方面的深厚经验，使其非常适合引领Rani进入下一个发展阶段。同时，我们也要再次感谢斯瓦伊·桑福德多年来的稳健领导及其为保障平稳交接所做的承诺。”","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4022","BK4139","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647232807","title":"益普生將以最高17.5億美元收購Kartos Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2647232807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647232807?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 13:20","pubTimestamp":1782710416,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年，FDA批准了51种新药，其中包括5种细胞和基因疗法2025年获批药物中，小分子药物占比超过67%，高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示，2025年美国监管机构批准的处方药上市价格虽较上年有所下降，但受罕见病高价药物影响，中位数仍高达216,000美元。基因疗法通常只需给药一次，其价格可能高达数百万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4532","JAZZ","IE00BN0W2W23.USD","LU0320765992.SGD","BK4007","BK4533","ABEO","BK4548","LU0154245756.USD","LU0882574055.USD","BK7508","LU0823416689.USD","BK4585","CSL.AU","LU0114720955.EUR","LU0154245673.USD","BK7007","BK4139","BK7501","BK4539","BK7067","IONS","BK4588","LU0109394709.USD","LENZ","IE00BN0W2T93.GBP","BK7511","NTI.AU","IE00BN0W2V16.EUR","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158361816","title":"Lenz Therapeutics與Arrotex Pharmaceuticals就Vizz™在澳大利亞和新西蘭達成獨家許可與商業化協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1158361816","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158361816?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 20:32","pubTimestamp":1782304365,"startTime":"0","endTime":"0","summary":"Lenz Therapeutics与Arrotex Pharmaceuticals宣布，双方已就Vizz™在澳大利亚和新西兰市场达成一项独家许可与商业化合作协议。该协议的签署标志着两家公司将在上述区域共同推进Vizz™的商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889615","title":"Definium Therapeutics(DFTX)宣佈7億美元增發公開募股定價 每股34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889615","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645889615?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 17:11","pubTimestamp":1782292315,"startTime":"0","endTime":"0","summary":"金吾财讯 | 临床后期生物制药公司Definium Therapeutics 正式宣布，其已完成扩大规模的包销公开发行定价，公司将以每股34.00美元的价格公开发行20,588,236股普通股。在不扣除承销折扣、佣金及其他发行费用的情况下，Definium预计此次公开发行的募资总额将达到约7亿美元。本次发行预计将于2026年6月25日左右交割。而就在本次发行定价前不久，Definium刚于6月22日宣布，其用于治疗重度抑郁症的创新疗法“DT120口崩片”在3期临床研究中取得了积极的顶线结果。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301833","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","UDN","DFTX","LENZ","UUP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":108,"code":"91000000","status":"200"}]}}